P20701 (ITAL_HUMAN) Homo sapiens (Human)

Integrin alpha-L UniProtKBInterProSTRINGInteractive Modelling

1170 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3)

Available Structures

41 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Structures of leukocyte integrin aLb2: The aI domain, the headpiece, and the pocket for the interna…
5e6u
 Heteromer
P05107; 		26-616
2×MG; 4×CA; 1×CL; 3×NAG;
Assess
Structures of leukocyte integrin aLb2: The aI domain, the headpiece, and the pocket for the interna…
5e6r
 Heteromer
P05107; 		26-615
1×MG; 4×CA; 4×NAG;
Assess
Structures of leukocyte integrin aLB2: The aI domain, the headpiece, and the pocket for the interna…
5e6s
 Heteromer
P05107; 		26-614
1×MG; 5×CA; 3×NAG;
Assess
Crystal structure of intermediate affinity I domain of integrin LFA-1 with the Fab fragment of its …
3hi6
 Heteromer
153-332
1×MN; 3×SO4;
Assess
crystal structure of ICAM-5 in complex with aL I domain
3bn3
 Heteromer
Q9UMF0; 		154-332
1×NAG; 1×MG; 4×NAG; 2×GOL;
Assess
Crystal structure the Fab fragment of Efalizumab in complex with LFA-1 I domain, Form I
3eoa
 Heteromer
153-331
Assess
Crystal structure the Fab fragment of Efalizumab in complex with LFA-1 I domain, Form II
3eob
 Heteromer
153-331
1×ZN;
Assess
Structure of Engineered Single Domain ICAM-1 D1 with High-Affinity aL Integrin I Domain of Native C…
3tcx
 Heteromer
P05362; 		154-332
1×MG;
Assess
Crystal structure of alphaL I domain in complex with ICAM-1
1mq8
 Heteromer
P05362; 		155-331
2×NAG; 2×NAG; 1×MG;
Assess
Structural Basis of ICAM recognition by integrin alpahLbeta2 revealed in the complex structure of b…
1t0p
 Heteromer
P32942; 		153-325
1×MG; 2×NAG;
Assess
CD11A I-DOMAIN WITH BOUND MN++
1lfa
homo-2-mer153-335
2×MN; 2×CL;
Assess
CD11A I-DOMAIN WITH BOUND MAGNESIUM ION
1zop
homo-2-mer153-335
2×MN; 2×CL;
Assess
CD11A I-DOMAIN WITH BOUND MAGNESIUM ION
1zoo
homo-2-mer153-335
2×MG; 2×CL;
Assess
LFA-1 I domain bound to inhibitors
3e2m
homo-2-mer153-334
2×E2M;
Assess
NMR SOLUTION STRUCTURE OF THE INSERTED DOMAIN OF HUMAN LEUKOCYTE FUNCTION ASSOCIATED ANTIGEN-1
1dgq
monomer149-336
Assess
X-ray structure of Lfa-1 I domain collected at 273 K
7kc3
monomer149-333
1×MG;
Assess
An allosteric inhibitor of LFA-1 bound to its I-domain
1rd4
monomer153-336
1×L08;
Assess
X-ray structure of lfa-1 i-domain in complex with ibe-667 at 1.8a resolution
4ixd
monomer153-334
1×MG; 1×1HV;
Assess
LFA-1 I domain bound to inhibitors
3bqn
monomer153-334
1×BQN;
Assess
X-ray structure of Lfa-1 I domain in complex with Lovastatin collected at 273 K
7kc6
monomer153-334
1×803; 1×MG;
Assess
X-ray structure of Lfa-1 I domain in complex with BMS-68852 collected at 273 K
7kc5
monomer153-334
1×MG; 1×BJZ;
Assess
LFA-1 I domain bound to inhibitors
3bqm
monomer153-334
1×BQM;
Assess
X-ray structure of LFA-1 I-domain in complex with LFA878 at 2.1A resolution
1xdg
monomer153-334
1×MG; 1×AB8;
Assess
X-ray structure of LFA-1 I-domain in complex with LFA703 at 2.2A resolution
1xdd
monomer153-334
1×MG; 1×AAY;
Assess
CRYSTAL STRUCTURE ANALYSIS OF THE COMPLEX LFA-1 (CD11A) I-DOMAIN / LOVASTATIN AT 2.6 A RESOLUTION
1cqp
monomer153-334
1×MG; 1×803;
Assess
X-ray structure of LFA-1 I-domain bound to a 1,4-diazepane-2,5-dione inhibitor at 1.8A resolution
1xuo
monomer153-333
1×MG; 1×LA1;
Assess
CD11A I-DOMAIN WITHOUT BOUND CATION
1zon
monomer153-333
Assess
Crystal structure of wild type LFA1 I domain complexed with isoflurane
3f78
monomer153-332
1×ICF; 1×GOL;
Assess
Crystal structure of wild type LFA1 I domain
3f74
monomer153-332
Assess
Crystal Structure of the intermediate affinity aL I domain mutant
1mjn
monomer153-331
1×MG;
Assess
CD11A (LFA1) I-domain complexed with 7A-[(4-cyanophenyl)methyl]-6-(3,5-dichlorophenyl)-5-oxo-2,3,5,…
2o7n
monomer154-332
1×2O7;
Assess
CD11A I-domain complexed with 6-((5S,9R)-9-(4-CYANOPHENYL)-3-(3,5-DICHLOROPHENYL)-1-METHYL-2,4-DIOX…
3m6f
monomer154-332
1×BJZ; 1×NO3;
Assess
Structure of a single-chain beta3 integrin
6bxj
monomer153-331
2×MG; 4×NAG;
Assess
Crystal structure of an extended b3 integrin P33
6bxb
monomer153-331
1×CA; 2×NAG; 2×GOL;
Assess
Crystal structure of an extended beta3 integrin P33
6ckb
monomer153-331
1×MG; 2×NAG;
Assess
Crystal structure of an extended b3 integrin L33
6bxf
monomer153-331
1×GOL; 3×NAG; 1×CA;
Assess
CD11a (LFA1) I-domain complexed with BMS-587101 aka 5-[(5S, 9R)-9-(4-cyanophenyl)-3-(3,5-dichloroph…
2ica
monomer154-331
1×2IC;
Assess
Crystal structure of high affinity alphaL I domain with ligand mimetic crystal contact
1mq9
monomer153-325
1×MN;
Assess
Crystal structure of high affinity alphaL I domain in the absence of ligand or metal
1mqa
monomer153-325
Assess
Solution structure of integrin Alpha L
2k8o
monomer1113-1170
Assess
The Integrin Alpha L Transmembrane Domain in Bicelles: Structure and Interaction with Integrin Beta…
2m3e
monomer1082-1128
Assess

8 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
5e6u.1.Amonomer0.8526-616
1×MG; 2×CA;99.60
Assess
7p2d.1.Amonomer0.6726-767
37.33
Assess
5es4.1.Amonomer0.6226-1083
1×MG;33.72
Assess
8t2v.1.Amonomer0.60346-1115
23.57
Assess
8zjf.1.Bmonomer0.5926-922
26.60
Assess
7usl.1.Amonomer0.5426-1083
1×CA;33.40
Assess
4cak.1.Amonomer0.51344-1098
22.60
Assess
6avu.1.Amonomer0.5026-1068
23.11
Assess

17 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 25e6u.1.Amonomer0.8526-616
1×MG; 2×CA;99.60
Assess
Isoform 27p2d.1.Amonomer0.6826-767
37.33
Assess
Isoform 25es4.1.Amonomer0.6226-1136
1×MG;33.65
Assess
Isoform 28zjf.1.Bmonomer0.5926-922
26.63
Assess
Isoform 28t2v.1.Amonomer0.53346-1168
23.15
Assess
Isoform 27nxd.1.Amonomer0.53349-1136
24.01
Assess
Isoform 35e6u.1.Amonomer0.7526-533
2×CA;98.34
Assess
Isoform 37p2d.1.Amonomer0.6226-683
37.63
Assess
Isoform 37p2d.1.Amonomer0.6076-683
39.20
Assess
Isoform 35es4.1.Amonomer0.6026-999
33.65
Assess
Isoform 38zjf.1.Bmonomer0.5726-838
26.63
Assess
Isoform 38t2v.1.Amonomer0.5526-1031
22.72
Assess
Isoform 37usl.1.Amonomer0.5526-999
1×CA;33.06
Assess
Isoform 36avu.1.Amonomer0.5326-984
22.32
Assess
Isoform 36avr.1.Amonomer0.5226-984
22.32
Assess
Isoform 36avq.1.Amonomer0.5226-984
22.32
Assess
Isoform 37nxd.1.Amonomer0.5226-999
23.98
Assess